中山醫學大學機構典藏 CSMUIR:Item 310902500/17911
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 17901/22917 (78%)
造訪人次 : 7662384      線上人數 : 290
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/17911


    題名: Mesenchymal stem cell insights: prospects in hematological transplantation
    作者: SH, Chou
    SZ, Lin
    CH, Day
    WW, Kuo
    CY, Shen
    DJ, Hsieh
    JY, Lin
    FJ, Tsai
    CH, Tsai
    CY, Huang
    貢獻者: 中山醫大
    日期: 2013
    上傳時間: 2017-07-04T08:37:08Z (UTC)
    出版者: Cell Transplant
    ISSN: 0963-6897
    摘要: Abstract
    Adult stem cells have been proven to possess tremendous potential in the treatment of hematological disorders, possibly in transplantation. Mesenchymal stem cells (MSCs) are a heterogeneous group of cells in culture, with hypoimmunogenic character to avoid alloreactive T-cell recognition as well as inhibition of T-cell proliferation. Numerous experimental findings have shown that MSCs also possess the ability to promote engraftment of donor cells and to accelerate the speed of hematological recovery. Despite that the exact mechanism remains unclear, the therapeutic ability of MSCs on hematologic transplantation have been tested in preclinical trials. Based on encouraging preliminary findings, MSCs might become a potentially efficacious tool in the therapeutic options available to treat and cure hematological malignancies and nonmalignant disorders. The molecular mechanisms behind the real efficacy of MSCs on promoting engraftment and accelerating hematological recovery are awaiting clarification. It is hypothesized that direct cell-to-cell contact, paracrine factors, extracellular matrix scaffold, BM homing capability, and endogenous metabolites of immunologic and nonimmunologic elements are involved in the interactions between MSCs and HSCs. This review focuses on recent experimental and clinical findings related to MSCs, highlighting their roles in promoting engraftment, hematopoietic recovery, and GvHD/graft rejection prevention after HSCT, discussing the potential clinical applications of MSC-based treatment strategies in the context of hematological transplantation.
    URI: http://dx.doi.org/10.3727/096368912X655172
    https://ir.csmu.edu.tw:8080/ir/handle/310902500/17911
    關聯: Cell Transplant. 2013;22(4):711-21.
    顯示於類別:[醫學檢驗暨生物技術學系暨碩士班] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML317檢視/開啟


    SFX Query

    在CSMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋